Chameleon Biosciences Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
17
- Latest Deal Type
-
Out of Business
Chameleon Biosciences General Information
Description
Developer of a gene delivery technology designed to overcome existing treatment barriers in gene therapy. The company's technology shields the capsid from antibodies reduces antibody production and masks foreign proteins to increase tolerance, enabling patients to have access to treatments for an increased number of diseases.
Contact Information
Website
www.chameleonbiosci.comCorporate Office
- 626 Bancroft Way
- Suite A
- Berkeley, CA 94710
- United States
Corporate Office
- 626 Bancroft Way
- Suite A
- Berkeley, CA 94710
- United States
Chameleon Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 04-Mar-2024 | Completed | Out of Business | |||
| 4. Later Stage VC | 27-Sep-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 25-Mar-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 25-Jun-2018 | $50K | $50K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-May-2018 | Completed | Generating Revenue |
Chameleon Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Chameleon Biosciences Comparisons
Industry
Financing
Details
Chameleon Biosciences Competitors (1)
One of Chameleon Biosciences’s competitors is Selecta Biosciences, a Formerly VC-backed company based in Watertown, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Selecta Biosciences | Formerly VC-backed | Watertown, MA |
Chameleon Biosciences Patents
Chameleon Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021297242-A1 | Extracellular vesicles with immune modulators | Inactive | 24-Jun-2020 | ||
| CA-3187321-A1 | Extracellular vesicles with immune modulators | Pending | 24-Jun-2020 | ||
| EP-4171596-A1 | Extracellular vesicles with immune modulators | Inactive | 24-Jun-2020 | ||
| US-20230355803-A1 | Extracellular vesicles with immune modulators | Inactive | 24-Jun-2020 | ||
| WO-2021262879-A1 | Extracellular vesicles with immune modulators | Inactive | 24-Jun-2020 | A61K9/1271 |
Chameleon Biosciences Signals
Chameleon Biosciences FAQs
-
When was Chameleon Biosciences founded?
Chameleon Biosciences was founded in 2017.
-
Where is Chameleon Biosciences headquartered?
Chameleon Biosciences is headquartered in Berkeley, CA.
-
What is the size of Chameleon Biosciences?
Chameleon Biosciences has 17 total employees.
-
What industry is Chameleon Biosciences in?
Chameleon Biosciences’s primary industry is Biotechnology.
-
Is Chameleon Biosciences a private or public company?
Chameleon Biosciences is a Private company.
-
What is Chameleon Biosciences’s current revenue?
The current revenue for Chameleon Biosciences is .
-
How much funding has Chameleon Biosciences raised over time?
Chameleon Biosciences has raised $11.2M.
-
Who are Chameleon Biosciences’s competitors?
Selecta Biosciences is a competitor of Chameleon Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process